Commentary: Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease (DIILD) Induced by Bleomycin
Main Authors: | Sotirios I. Sinis, Sotirios G. Zarogiannis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphys.2021.691650/full |
Similar Items
-
Imaging Biomarkers and Pathobiological Profiling in a Rat Model of Drug-Induced Interstitial Lung Disease Induced by Bleomycin
by: Irma Mahmutovic Persson, et al.
Published: (2020-06-01) -
Carbon Nanotubes and Other Engineered Nanoparticles Induced Pathophysiology on Mesothelial Cells and Mesothelial Membranes
by: Sotirios I. Sinis, et al.
Published: (2018-03-01) -
A case of bleomycin-induced lung toxicity
by: Cuneyt Tetikkurt, et al.
Published: (2018-11-01) -
Intralesional Interstitial Injection of Bleomycin for Management of Extracranial Arteriovenous Malformations in Children
by: Yun ZOU, et al.
Published: (2021-06-01) -
Spontaneous Pneumomediastinum and Bilateral Pneumothoraces in a Patient with Bleomycin-Induced Pneumonitis
by: Matthieu Barras, et al.
Published: (2017-10-01)